Transaction in Own Shares

For immediate release

                                                                  30 April 2010

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                    MARKET PURCHASE OF COMPANY'S OWN SHARES                    

Notification is given, pursuant to the authority granted at a General Meeting
of the Company held on 2 March 2010 to make market purchases of the Company's
own shares up to an aggregate maximum of 6,716,138 that a market total of
96,989 Ordinary shares of 25p each in the capital of the Company were purchased
today by the Company at a price of 678.23p per share. These shares will be held
in treasury.

Following this transaction and in conformity with the provisions of the
Transparency Directive, the Company hereby notifies the market that: the total
number of Ordinary shares held by the Company in treasury following the
purchase is 6,589,176 and the total number of Ordinary shares that the Company
has in issue, less the total number of Ordinary shares held by the Company in
treasury following such purchase, and therefore, the total number of voting
rights in the Company is 43,986,996.

The figure of 43,986,996 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FSA's
Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: [phone]